Biofrontera (BFRI) Tax Provisions (2020 - 2025)
Biofrontera's (BFRI) quarterly Tax Provisions came in at -$2.2 million in Q4 2025, down 74300.0% year-on-year from N/an in Q4 2024, and down 37300.0% quarter-over-quarter from $6000.0 in Q3 2025.
Biofrontera (BFRI) Tax Provisions (2020 - 2025) Analysis & Trends
Biofrontera's Tax Provisions history runs 6 years deep, the most recent figure standing at -$2.2 million for Q4 2025.
- On a quarterly basis, Tax Provisions fell 74300.0% year-over-year to -$2.2 million in Q4 2025; TTM through Dec 2025 was -$2.2 million, a 10604.76% decrease from a year earlier, with the FY2025 full-year figure at -$2.2 million, down 10131.82% from the prior year.
- Tax Provisions declined to -$2.2 million in Q4 2025 per BFRI's latest filing, from $6000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $44000.0 in Q2 2021 and bottomed at -$2.2 million in Q4 2025.
- The 5-year median for Tax Provisions is $3000.0 (2024), against an average of -$109631.6.
- Across the five-year window, Tax Provisions surged 2900.0% in 2022 and plunged 74300.0% in 2025, its largest moves.
- Year by year, Tax Provisions stood at $5000.0 in 2021, then slumped by 80.0% to $1000.0 in 2022, then slumped by 700.0% to -$6000.0 in 2023, then surged by 50.0% to -$3000.0 in 2024, then plunged by 74300.0% to -$2.2 million in 2025.
- Per Business Quant, the three latest BFRI Tax Provisions figures stand at -$2.2 million (Q4 2025), $6000.0 (Q3 2025), and $21000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 67.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 157.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 676.90 Mn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 43.40 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -423.70 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 48.90 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 30.00 Mn |
| 10 | Biofrontera | 11.04 Mn | 4.63 Mn | 14.09 Mn | -2.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.23 Mn |
| Sep 30, 2025 | 6,000.00 |
| Jun 30, 2025 | 21,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Dec 31, 2024 | -3,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 20,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Dec 31, 2023 | -6,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 14,000.00 |
| Mar 31, 2023 | 5,000.00 |
| Dec 31, 2022 | 1,000.00 |
| Sep 30, 2022 | 1,000.00 |
| Mar 31, 2022 | 30,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 6,000.00 |
| Jun 30, 2021 | 44,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Dec 31, 2020 | -2,000.00 |